Open an account

Marpai

MRAI · OTC

$3.17−$0.014 (−0.44%)TodayMarket closed ·
Prev close $3.18

About MRAI

Marpai, Inc. offers a SMART health plan services system that transforms health plan into a health empowerment tool. The company is headquartered in Tampa, Florida and currently employs 107 full-time employees. The company went IPO on 2021-10-27. The firm operates subsidiaries that provide Third Party Administrator and value-oriented health plan services to employers that directly pay for employee health benefits. Its products and services include Health Plan Administration services, In-House Ancillary services, and Third-Party Vendor services. Its Health Plan Administration services offering includes handling all aspects of administration related to a healthcare plan. Its In-House Ancillary Services are derived from its in-house products related to its role as the administrator of the clients' health plans. The firm typically design healthcare benefit plan for its client, which allows the client to define the coverage it would like to provide to its employees. The firm offers MarpaiRx, a national pharmacy benefit management program.

Employees
107
Headquarters
Tampa, Florida
Listed
Oct 27, 2021
Sector
Financials
Industry
Insurance
Website
marpaihealth.com

MRAI key statistics

Market cap
84.94M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
19.83K
Volume
3.30K
Open price
$3.18
High today
$3.18
Low today
$3.16
52 Week high
$4.16
52 Week low
$0.215

Marpai (MRAI) at a glance

Marpai (MRAI) last traded at $3.17, with a market cap of 84.94M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $3.16 and $3.18. The current price is 0.2% above the day's low and 0.4% below its high.

Volume so far is 3.30K shares, below the average of 19.83K shares a day.

Over the past year Marpai has ranged from $0.215 to $4.16, and now sits 75% of the way up that range.

Marpai met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q1 FY24 it reported -$0.46 per share against an estimate of -$0.4386.

MRAI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 24.3% on average.

  1. Q2 FY22: reported -$1.12 per share against an estimate of -$1.10
  2. Q3 FY22: reported -$1.00 per share against an estimate of -$1.06
  3. Q4 FY22: reported -$1.48 per share against an estimate of -$1.92
  4. Q1 FY23: reported -$1.56 per share against an estimate of -$1.51
  5. Q2 FY23: reported -$1.00 per share against an estimate of -$1.31
  6. Q3 FY23: reported -$0.98 per share against an estimate of -$0.9384
  7. Q4 FY24: reported -$0.14 per share against an estimate of -$0.255
  8. Q1 FY24: reported -$0.46 per share against an estimate of -$0.4386

MRAI news

  • Press releaseBusiness Wire

    Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients

  • Press releasePRNewswire

    Marpai Reports Second Quarter 2026 Financial Results

  • Press releasePRNewswire

    Marpai Announces $12 Million Private Placement led by Mitchell Companies

  • Press releasePRNewswire

    Marpai Inc. Announces Debt Restructuring Agreements with JGB Capital and AXA, Reducing Debt Service by $26.4 Million Through 2027 and Enhances Near term Liquidity

  • Press releasePRNewswire

    Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026

  • Press releasePRNewswire

    MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

  • Press releasePRNewswire

    Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability

  • Press releasePRNewswire

    Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide

Similar companies

Companies in the same industry as Marpai

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.